Literature DB >> 20023376

An emerging role for class I bHLH E2-2 proteins in EMT regulation and tumor progression.

Amparo Cano1, Francisco Portillo.   

Abstract

EMT is a complex process whereby cells lose cell-cell interactions and other epithelial properties whilst acquiring a migratory and mesenchymal phenotype. EMT is presently recognized as an important even for tumor invasion and metastasis. Functional E-cadherin loss is a hallmark of EMT and required for tumor invasion in the majority of carcinomas. Transcriptional downregulation is one of the major mechanisms for E-cadherin suppression in carcinomas. In the last decade several E-cadherin repressors, belonging to different transcriptional families, have been identified that, importantly, also act as potent EMT inducers. One of the last additions to EMT regulators are the class I bHLH factors E2-2 (also known as TCF4). However, the hierarchical and functional interrelations between the different EMT inducers are still poorly understood. Here, we comment on the new and so far unrecognized function of E2-2 factors in EMT and discuss on the potential interactions among various EMT inducers. Emerging evidence supporting the participation of TCF4 in human malignancies is also discussed. Thus, increasing understanding of EMT and its regulators is providing meaningful insights into the present knowledge on tumor progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20023376      PMCID: PMC2852558          DOI: 10.4161/cam.4.1.9995

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  47 in total

1.  Analysis of the inhibition of MyoD activity by ITF-2B and full-length E12/E47.

Authors:  H Petropoulos; I S Skerjanc
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

Review 2.  Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms.

Authors:  M E Massari; C Murre
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

3.  The basic helix-loop-helix transcription factor E2-2 is involved in T lymphocyte development.

Authors:  I Bergqvist; M Eriksson; J Saarikettu; B Eriksson; B Corneliussen; T Grundström; D Holmberg
Journal:  Eur J Immunol       Date:  2000-10       Impact factor: 5.532

4.  Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression.

Authors:  Sandra Guaita; Isabel Puig; Clara Franci; Marta Garrido; David Dominguez; Eduard Batlle; Elena Sancho; Shoukat Dedhar; Antonio Garcia De Herreros; Josep Baulida
Journal:  J Biol Chem       Date:  2002-08-02       Impact factor: 5.157

Review 5.  Epithelial-mesenchymal transitions in tumour progression.

Authors:  Jean Paul Thiery
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

6.  A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions.

Authors:  M A Perez-Moreno; A Locascio; I Rodrigo; G Dhondt; F Portillo; M A Nieto; A Cano
Journal:  J Biol Chem       Date:  2001-04-17       Impact factor: 5.157

7.  HASH-1 and E2-2 are expressed in human neuroblastoma cells and form a functional complex.

Authors:  P Persson; A Jögi; A Grynfeld; S Påhlman; H Axelson
Journal:  Biochem Biophys Res Commun       Date:  2000-07-21       Impact factor: 3.575

8.  Involvement of ITF2 in the transcriptional regulation of melanogenic genes.

Authors:  M Furumura; S B Potterf; K Toyofuku; J Matsunaga; J Muller; V J Hearing
Journal:  J Biol Chem       Date:  2001-05-29       Impact factor: 5.157

9.  ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.

Authors:  Frank T Kolligs; Marvin T Nieman; Ira Winer; Gang Hu; David Van Mater; Ying Feng; Ian M Smith; Rong Wu; Yali Zhai; Kathleen R Cho; Eric R Fearon
Journal:  Cancer Cell       Date:  2002-03       Impact factor: 31.743

10.  A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis.

Authors:  Marjon A Smit; Thomas R Geiger; Ji-Ying Song; Inna Gitelman; Daniel S Peeper
Journal:  Mol Cell Biol       Date:  2009-05-04       Impact factor: 4.272

View more
  16 in total

Review 1.  The Molecular Basis of Fuchs' Endothelial Corneal Dystrophy.

Authors:  Jie Zhang; Charles N J McGhee; Dipika V Patel
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

Review 2.  Regulatory networks defining EMT during cancer initiation and progression.

Authors:  Bram De Craene; Geert Berx
Journal:  Nat Rev Cancer       Date:  2013-02       Impact factor: 60.716

3.  Association and familial segregation of CTG18.1 trinucleotide repeat expansion of TCF4 gene in Fuchs' endothelial corneal dystrophy.

Authors:  V Vinod Mootha; Xin Gong; Hung-Chih Ku; Chao Xing
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-02       Impact factor: 4.799

4.  CTG18.1 repeat expansion may reduce TCF4 gene expression in corneal endothelial cells of German patients with Fuchs' dystrophy.

Authors:  Sabine Foja; Mirjam Luther; Katrin Hoffmann; Andreas Rupprecht; Claudia Gruenauer-Kloevekorn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-12       Impact factor: 3.117

5.  Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors.

Authors:  Sujan Kumar Mondal; Sudhakar Jinka; Krishnendu Pal; Swetha Nelli; Shamit Kumar Dutta; Enfeng Wang; Ajaz Ahmad; Khalid M AlKharfy; Debabrata Mukhopadhyay; Rajkumar Banerjee
Journal:  Mol Pharm       Date:  2016-06-01       Impact factor: 4.939

6.  Comprehensive assessment of genetic variants within TCF4 in Fuchs' endothelial corneal dystrophy.

Authors:  Eric D Wieben; Ross A Aleff; Bruce W Eckloff; Elizabeth J Atkinson; Saurabh Baheti; Sumit Middha; William L Brown; Sanjay V Patel; Jean-Pierre A Kocher; Keith H Baratz
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-28       Impact factor: 4.799

7.  Pitt-Hopkins syndrome: phenotypic and genotypic description of four unrelated patients and structural analysis of corresponding missense mutations.

Authors:  Tingting Zhao; Georgi Z Genchev; Shengnan Wu; Guangjun Yu; Hui Lu; Jincai Feng
Journal:  Neurogenetics       Date:  2021-06-14       Impact factor: 2.660

8.  E47 and Id1 interplay in epithelial-mesenchymal transition.

Authors:  Eva Cubillo; Antonio Diaz-Lopez; Eva P Cuevas; Gema Moreno-Bueno; Hector Peinado; Amalia Montes; Vanesa Santos; Francisco Portillo; Amparo Cano
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

9.  Sohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8.

Authors:  Shufang Ji; Wenfang Zhang; Xiaoli Zhang; Chunyan Hao; Aijun Hao; Qing Gao; Hongying Zhang; Jinhao Sun; Jing Hao
Journal:  Oncotarget       Date:  2016-08-02

Review 10.  Genetic mutations and molecular mechanisms of Fuchs endothelial corneal dystrophy.

Authors:  Xuerui Liu; Tao Zheng; Chuchu Zhao; Yi Zhang; Hanruo Liu; Liyuan Wang; Ping Liu
Journal:  Eye Vis (Lond)       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.